Voyager Therapeutics appoints Jacquelyn Fahey Sandell as Chief Legal Officer

Voyager Therapeutics, Inc.

Jacquelyn Fahey Sandell named CLO effective July 10, 2023; reports to CEO Alfred Sandrock.
Base salary of $450,000 per year; eligible for annual cash bonus at 40% of base salary target.
Inducement equity grant: option to purchase 122,000 shares (4-year vest) and RSU for 61,000 shares (3-year vest).
Severance includes 12 months base salary, pro-rata target bonus, COBRA subsidy, and full equity acceleration upon qualifying termination within 12 months of a sale event.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.